ATRT-19. RARE EMBRYONAL TUMORS INCLUDING EMBRYONAL TUMOR MULTILAYER ROSETTE, OUTCOME AND PATTERN OF TREATMENT FAILURE: MD ANDERSON CANCER CENTER EXPERIENCE
Jiasen He(The University of Texas MD Anderson Cancer Center), Wafik Zaky(The University of Texas MD Anderson Cancer Center), David I. Sandberg(The University of Texas MD Anderson Cancer Center), Susan L. McGovern(Northwestern University), Jason M. Johnson(Yale University), Arnold C. Paulino(The University of Texas MD Anderson Cancer Center), Faryal Munir(The University of Texas MD Anderson Cancer Center), Irtiza Sheikh(The University of Texas MD Anderson Cancer Center)
Cited by 0
Related Papers
Molecular Docking and High-Throughput Screening for Novel Inhibitors of Protein Tyrosine Phosphatase-1B
|Journal of Medicinal Chemistry|2002|467
Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly‐diagnosed with central nervous system atypical teratoid/rhabdoid tumors: The head start III experience
|Pediatric Blood & Cancer|2013|110
Classical Hodgkin Lymphoma: From Past to Future—A Comprehensive Review of Pathophysiology and Therapeutic Advances
|International Journal of Molecular Sciences|2023|54
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies
|Leukemia|2023|52
The Children's Oncology Group Radiation Oncology Discipline: 15 Years of Contributions to the Treatment of Childhood Cancer
|International Journal of Radiation Oncology*Biology*Physics|2018|47